-

cbdMD, Inc. to Participate in Jefferies Investor Conference

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and best recognized CBD companies, announced that on Tuesday, November 16, 2021, the Company will participate in the Jefferies Virtual West Coast Consumer Conference. The fireside chat will begin at 9:50 AM ET.

Investors interested in listening to the fireside chat live, please use the provided link, https://wsw.com/webcast/jeff210/ycbd/1823004 to sign in prior to the 9:50 AM ET start.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading, most highly trusted and most recognized cannabidiol (CBD) brands, with a comprehensive line of U.S.-produced, THC-free1 CBD products. The cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids, CBD drink mixes and full spectrum CBD options. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products, including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, facial masks, exfoliants and body care. The company also offers a line of full spectrum products (approximately 10 SKUs) under its cbdMD brand. To learn more about cbdMD and their comprehensive line of U.S.-grown, THC-free1 CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the 6,000 retail outlets that carry cbdMD products.

1 THC-free is defined as below the level of detection using validated scientific analytical methods.

Contacts

PR:
cbdMD, Inc.
Robert Pettway
Director of Public Relations
rpettway@cbdmd.com
(423) 503-5225

Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
john.weston@cbdmd.com
(704) 249-9515

Industry:

cbdMD, Inc.

NYSEAM:YCBD
Release Versions
English

Contacts

PR:
cbdMD, Inc.
Robert Pettway
Director of Public Relations
rpettway@cbdmd.com
(423) 503-5225

Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
john.weston@cbdmd.com
(704) 249-9515

More News From cbdMD, Inc.

cbdMD™ Makes History Becoming the First CBD Brand to Achieve 3 NSF’s Certified for Sport® Certifications

CHARLOTTE, N.C.--(BUSINESS WIRE)--New suite of products allows professionals from all walks of life to add CBD to their regimen without fear of failing a drug test for THC....

cbdMD Expands Product Offering and Nationwide Footprint with Major Retail Partner GNC

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, has announced an expansion in product offerings online and in over 840 retail GNC Holdings, LLC (GNC) stores nationwide. cbdMD first partnered with GNC in August 2020, and included a roll-out of three topical SKUs at under 100 retail stores nationwide. Due to consumer receptivity and overall purchasing...

cbdMD Requests the Food and Drug Administration (FDA) Remove the Drug Exclusion for CBD and Review cbdMD’s Extensive Safety Submission

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the world’s leading and most highly trusted and recognized health & wellness CBD companies, today announced that the Natural Products Association (NPA) filed a Citizen’s Petition on cbdMD’s behalf with the Food and Drug Administration (FDA) requesting the FDA to remove the drug exclusion for CBD and to review the Company’s extensive dossier of identity, safety and quality data. Removing the d...
Back to Newsroom